4.8 Article

Cross-Kingdom Chemical Communication Drives a Heritable, Mutually Beneficial Prion-Based Transformation of Metabolism

期刊

CELL
卷 158, 期 5, 页码 1083-1093

出版社

CELL PRESS
DOI: 10.1016/j.cell.2014.07.025

关键词

-

资金

  1. G. Harold and Leila Y. Mathers Foundation
  2. Howard Hughes Medical Institute (HHMI
  3. HHMI fellow of the Damon Runyon Cancer Research Foundation [DRG-1964-08]
  4. NIH Pathway to independence award [K99 GM098600]

向作者/读者索取更多资源

In experimental science, organisms are usually studied in isolation, but in the wild, they compete and cooperate in complex communities. We report a system for cross-kingdom communication by which bacteria heritably transform yeast metabolism. An ancient biological circuit blocks yeast from using other carbon sources in the presence of glucose. [GAR(+)], a protein-based epigenetic element, allows yeast to circumvent this glucose repression'' and use multiple carbon sources in the presence of glucose. Some bacteria secrete a chemical factor that induces [GAR(+)]. [GAR(+)] is advantageous to bacteria because yeast cells make less ethanol and is advantageous to yeast because their growth and long-term viability is improved in complex carbon sources. This cross-kingdom communication is broadly conserved, providing a compelling argument for its adaptive value. By heritably transforming growth and survival strategies in response to the selective pressures of life in a biological community, [GAR(+)] presents a unique example of Lamarckian inheritance.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins

Samagya Banskota, Aditya Raguram, Susie Suh, Samuel W. Du, Jessie R. Davis, Elliot H. Choi, Xiao Wang, Sarah C. Nielsen, Gregory A. Newby, Peyton B. Randolph, Mark J. Osborn, Kiran Musunuru, Krzysztof Palczewski, David R. Liu

Summary: We have developed and applied engineered DNA-free virus-like particles (eVLPs) for efficient delivery of gene editing tools, achieving high levels of base editing. By overcoming the limitations of cargo packaging, release, and localization, the fourth-generation eVLPs demonstrated efficient base editing in mouse and human cells. In addition, the off-target effects of eVLPs were significantly reduced compared to other delivery methods such as AAV or plasmid.
Article Biotechnology & Applied Microbiology

Disruption of HIV-1 co-receptors CCR5 and CXCR4 in primary human T cells and hematopoietic stem and progenitor cells using base editing

Friederike Knipping, Gregory A. Newby, Cindy R. Eide, Amber N. McElroy, Sarah C. Nielsen, Kyle Smith, Yongxing Fang, Tatjana Cornu, Caroline Costa, Alejandra Gutierrez-Guerrero, Samuel P. Bingea, Colby J. Feser, Benjamin Steinbeck, Keli L. Hippen, Bruce R. Blazar, Anton McCaffrey, Claudio Mussolino, Els Verhoeyen, Jakub Tolar, David R. Liu, Mark J. Osborn

Summary: The disruption of CCR5 and CXCR4 co-receptors using base editing techniques has been shown to protect CD4(+) T cells from HIV-1 infection. The base editing strategies effectively introduce targeted mutations to inactivate the genes without causing double stranded DNA breaks. This study demonstrates the potential of base-editing strategies in preventing viral transduction and maintaining cellular functionality.

MOLECULAR THERAPY (2022)

Review Oncology

Biomolecular Condensation: A New Phase in Cancer Research

Anupam K. Chakravarty, Daniel J. McGrail, Thomas M. Lozanoski, Brandon S. Dunn, David J. H. Shih, Kara M. Cirillo, Sueda H. Cetinkaya, Wenjin Jim Zheng, Gordon B. Mills, S. Stephen Yi, Daniel F. Jarosz, Nidhi Sahni

Summary: Multicellularity was a crucial development in evolution, but it also led to the occurrence of cancer as individual cells can evade regulatory mechanisms. Recent research has shown that many biomolecules can undergo phase separation and reorganize cellular biochemistry, which has sparked a surge in studying the mechanistic connections between phase separation and cancer.

CANCER DISCOVERY (2022)

Article Microbiology

A dissemination-prone morphotype enhances extrapulmonary organ entry by Cryptococcus neoformans

Steven T. Denham, Brianna Brammer, Krystal Y. Chung, Morgan A. Wambaugh, Joseph M. Bednarek, Li Guo, Christian T. Moreau, Jessica C. S. Brown

Summary: This research reveals the critical role of seed cells, a small morphotype of Cryptococcus neoformans, in the invasion of extrapulmonary organs. The formation of seed cells is triggered by environmental factors, and they exhibit enhanced interaction with macrophages. Phosphate from pigeon guano plays a central role in the formation of seed cells.

CELL HOST & MICROBE (2022)

Article Biotechnology & Applied Microbiology

Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity

Monica E. Neugebauer, Alvin Hsu, Mandana Arbab, Nicholas A. Krasnow, Amber N. McElroy, Smriti Pandey, Jordan L. Doman, Tony P. Huang, Aditya Raguram, Samagya Banskota, Gregory A. Newby, Jakub Tolar, Mark J. Osborn, David R. Liu

Summary: Improved cytosine base editors are generated by phage-assisted evolution of a deoxyadenosine deaminase, which exhibit small size, low off-target activity, and high on-target activity. These modified base editors have significant application potential in cell and gene editing.

NATURE BIOTECHNOLOGY (2023)

Article Multidisciplinary Sciences

ABE8e adenine base editor precisely and efficiently corrects a recurrent COL7A1 nonsense mutation

Adam Sheriff, Ina Guri, Paulina Zebrowska, Virginia Llopis-Hernandez, Imogen R. Brooks, Stavroula Tekkela, Kavita Subramaniam, Ruta Gebrezgabher, Gaetano Naso, Anastasia Petrova, Katarzyna Balon, Alexandros Onoufriadis, Dorota Kujawa, Martyna Kotulska, Gregory Newby, Lukasz Laczmanski, David R. Liu, John A. McGrath, Joanna Jackow

Summary: This study demonstrates the use of the adenine base editor ABE8e to correct gene mutations in RDEB patient fibroblasts. The results show efficient correction of the pathogenic allele and restoration of protein expression. This research lays the foundation for developing base editing strategies to treat RDEB patients.

SCIENTIFIC REPORTS (2022)

Article Biotechnology & Applied Microbiology

A prime editor mouse to model a broad spectrum of somatic mutations in vivo

Zackery A. Ely, Nicolas Mathey-Andrews, Santiago Naranjo, Samuel I. Gould, Kim L. Mercer, Gregory A. Newby, Christina M. Cabana, William M. Rideout III, Grissel Cervantes Jaramillo, Jennifer M. Khirallah, Katie Holland, Peyton B. Randolph, William A. Freed-Pastor, Jessie R. Davis, Zachary Kulstad, Peter M. K. Westcott, Lin Lin, Andrew V. Anzalone, Brendan L. Horton, Nimisha B. Pattada, Sean-Luc Shanahan, Zhongfeng Ye, Stefani Spranger, Qiaobing Xu, Francisco J. Sanchez-Rivera, David R. Liu, Tyler Jacks

Summary: Genetically engineered mouse models have limitations in capturing the full range of genetic lesions that drive human cancer. However, a new CRISPR-Cas9 model has been developed to expand this scope through in vivo prime editing. This system allows for precise engineering of various mutations in cell lines and organoids derived from primary tissues, making it possible to study cancer-associated mutations and complex genetic combinations that are challenging with traditional models.

NATURE BIOTECHNOLOGY (2023)

Article Biotechnology & Applied Microbiology

Efficient prime editing in mouse brain, liver and heart with dual AAVs

Jessie R. Davis, Samagya Banskota, Jonathan M. Levy, Gregory A. Newby, Xiao Wang, Andrew V. Anzalone, Andrew T. Nelson, Peter J. Chen, Andrew D. Hennes, Meirui An, Heejin Roh, Peyton B. Randolph, Kiran Musunuru, David R. Liu

Summary: Efficient methods for delivering prime editors (PEs) in vivo are needed to realize the promise of prime editing for the study and treatment of genetic disorders. This study describes the identification of bottlenecks limiting adeno-associated virus (AAV)-mediated prime editing in vivo and the development of AAV-PE vectors with increased efficiency. The optimized PE-AAV systems support high levels of in vivo prime editing and enable therapeutically relevant editing in mouse organs.

NATURE BIOTECHNOLOGY (2023)

Article Multidisciplinary Sciences

Base editing rescue of spinal muscular atrophy in cells and in mice

Mandana Arbab, Zaneta Matuszek, Kaitlyn M. Kray, Ailing Du, Gregory A. Newby, Anton J. Blatnik, Aditya Raguram, Michelle F. Richter, Kevin T. Zhao, Jonathan M. Levy, Max W. Shen, W. David Arnold, Dan Wang, Jun Xie, Guangping Gao, Arthur H. M. Burghes, David R. Liu

Summary: Spinal muscular atrophy (SMA), a leading genetic cause of infant mortality, can be treated by genome editing of SMN2 to restore SMN protein levels and rescue SMA phenotypes, demonstrating the potential of a one-time base editing treatment for SMA.

SCIENCE (2023)

Article Engineering, Biomedical

Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice

Kelcee A. Everette, Gregory A. Newby, Rachel M. Levine, Kalin Mayberry, Yoonjeong Jang, Thiyagaraj Mayuranathan, Nikitha Nimmagadda, Erin Dempsey, Yichao Li, Senthil Velan Bhoopalan, Xiong Liu, Jessie R. Davis, Andrew T. Nelson, Peter J. Chen, Alexander A. Sousa, Yong Cheng, John F. Tisdale, Mitchell J. Weiss, Jonathan S. Yen, David R. Liu

Summary: Prime editing efficiently corrects the sickle-cell allele in patient haematopoietic stem cells, resulting in erythrocytes resistant to hypoxia-induced sickling. This correction was achieved at frequencies of 15%-41% in patients with sickle-cell disease. After transplantation into mice, the prime-edited cells maintained normal gene expression and displayed similar differentiation and maturation as unedited stem cells from healthy donors.

NATURE BIOMEDICAL ENGINEERING (2023)

Article Genetics & Heredity

Potent and uniform fetal hemoglobin induction via base editing

Thiyagaraj Mayuranathan, Gregory A. Newby, Ruopeng Feng, Yu Yao, Kalin D. Mayberry, Cicera R. Lazzarotto, Yichao Li, Rachel M. Levine, Nikitha Nimmagadda, Erin Dempsey, Guolian Kang, Shaina N. Porter, Phillip A. Doerfler, Jingjing Zhang, Yoonjeong Jang, Jingjing Chen, Henry W. Bell, Merlin Crossley, Senthil Velan Bhoopalan, Akshay Sharma, John F. Tisdale, Shondra M. Pruett-Miller, Yong Cheng, Shengdar Q. Tsai, David R. Liu, Mitchell J. Weiss, Jonathan S. Yen

Summary: A comparison of gene editing strategies using sickle cell disease cells and in vivo transplantation reveals that adenine base editing of the -175A>G site in the γ-globin gene promoters yields durable and potent expression. This approach provides insights into γ-globin gene regulation and offers a potential strategy for inducing HbF. The study also highlights the unexpected phenotypic variation caused by Cas9-generated diverse indels, which can be avoided by base editing.

NATURE GENETICS (2023)

Article Multidisciplinary Sciences

Defining the condensate landscape of fusion oncoproteins

Swarnendu Tripathi, Hazheen K. Shirnekhi, Scott D. Gorman, Bappaditya Chandra, David W. Baggett, Cheon-Gil Park, Ramiz Somjee, Benjamin Lang, Seyed Mohammad Hadi Hosseini, Brittany J. Pioso, Yongsheng Li, Ilaria Iacobucci, Qingsong Gao, Michael N. Edmonson, Stephen V. Rice, Xin Zhou, John Bollinger, Diana M. Mitrea, Michael R. White, Daniel J. McGrail, Daniel F. Jarosz, S. Stephen Yi, M. Madan Babu, Charles G. Mullighan, Jinghui Zhang, Nidhi Sahni, Richard W. Kriwacki

Summary: Fusion oncoproteins have been found to form condensates with distinct physicochemical features, subcellular localization, and biological function. By Machine Learning, a predictor of condensation behavior was developed and it was discovered that approximately 67% of additional fusion oncoproteins likely form condensates.

NATURE COMMUNICATIONS (2023)

Article Medicine, Research & Experimental

Nonviral base editing of KCNJ13 mutation preserves vision in a model of inherited retinal channelopathy

Meha Kabra, Pawan K. Shahi, Yuyuan Wang, Divya Sinha, Allison Spillane, Gregory A. Newby, Shivani Saxena, Yao Tong, Yu Chang, Amr A. Abdeen, Kimberly L. Edwards, Cole O. Theisen, David R. Liu, David M. Gamm, Shaoqin Gong, Krishanu Saha, Bikash R. Pattnaik

Summary: Clinical genome editing is being used to treat rare diseases, but the delivery of CRISPR editors remains a challenge. In this study, we used silica nanocapsules to deliver base editors to the retinal pigmented epithelium for the treatment of retinal degeneration. The base editor effectively corrected point mutations in the KCNJ13 gene and restored functional channels. This preclinical validation of targeted ion channel functional rescue demonstrates the effectiveness of nonviral genome-editing therapy for rare inherited disorders.

JOURNAL OF CLINICAL INVESTIGATION (2023)

Meeting Abstract Biophysics

A colloidal polymer model for the condensnation of intrinsically disordered proteins

Theodore Yang, Daniel Jarosz, Roseanna N. Zia

BIOPHYSICAL JOURNAL (2022)

Correction Biotechnology & Applied Microbiology

Engineered pegRNAs improve prime editing efficiency (vol 40, pg 402, 2022)

James W. Nelson, Peyton B. Randolph, Simon P. Shen, Kelcee A. Everette, Peter J. Chen, Andrew V. Anzalone, Meirui An, Gregory A. Newby, Jonathan C. Chen, Alvin Hsu, David R. Liu

NATURE BIOTECHNOLOGY (2022)

暂无数据